Spots Global Cancer Trial Database for Drug-loadable（T-ACE Beads）for Hepatoma Embolization Therapy

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Drug-loadable（T-ACE Beads）for Hepatoma Embolization Therapy

Official Title: Hydrophilic Radiopaque Microsphere With Doxorubicin for Hepatoma Embolization Therapy

Study ID: NCT03299036

Conditions

Cancer of Liver

Interventions

Taiwan ACE Beads with doxorubicin

Study Description

Brief Summary: The purpose of this study is to evaluate the safety and efficacy of Radiopaque Microsphere (T-ACE Beads with doxorubicin) interventional therapy for patients with liver cancer

Detailed Description: The study will evaluate the safety and tolerability of Taiwan ACE Beads with doxorubicin used for chemoembolization for the treatment of unresectable hepatocellular carcinoma. The investigators will study the overall response rates of lesions with Taiwan ACE Beads. The procedure is similar with the other commercializing drug-eluting beads. At the target vessels, radiologists will inject doxorubicin with Taiwan ACE Beads instead of Gelfoam or PVA (polyvinyl alcohol). The end point of injection is also similar with conventional TACE. Determine the complication rates, progression free survival (PFS) and overall survival (OS) following Taiwan ACE Beads embolization.